Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/15/2002US6465173 Diagnosis, therapy aids
10/15/2002US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/15/2002US6464980 MAGE-1 c-terminal immunogenic peptides
10/15/2002US6464974 Immunosuppressant target proteins
10/15/2002CA2263725C Immortalized cell lines for virus growth
10/15/2002CA2261964C New tumor suppressor gene and the protein coded thereby, methods of production and use thereof
10/15/2002CA2106675C Enzymatic process for the preparation of macrolactone
10/10/2002WO2002079781A1 Methods of detecting early renal disease in animals
10/10/2002WO2002079468A2 A method of increasing complementarity in a heteroduplex polynucleotide
10/10/2002WO2002079457A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079399A2 Regulatable growth of filamentous fungi
10/10/2002WO2002079381A2 Biosynthesis of s-adenosylmethionine in a recombinant yeast strain
10/10/2002WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002WO2002079256A1 Antibody and utilization thereof
10/10/2002WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002WO2002079254A1 Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae
10/10/2002WO2002079250A1 Insulin precursors and a process for their preparation
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079228A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002WO2002079226A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/10/2002WO2002079217A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078734A1 Production of peptides in plants as n-terminal viral coat protein fusions
10/10/2002WO2002078642A2 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer
10/10/2002WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002WO2002078638A2 Morpholino imaging and therapy
10/10/2002WO2002078631A2 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002WO2002078603A2 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/10/2002WO2002078600A2 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA
10/10/2002WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002029045A3 Method for the production of vitamin k-dependent proteins
10/10/2002WO2002029025A3 Factor vii glycoforms
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002004007A9 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002US20020147329 Method of modulating tissue growth using Frzb protein
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147324 RPS gene family, primers, probes, and detection methods
10/10/2002US20020147315 Method for removing endotoxin from the samples containing basic protein
10/10/2002US20020147310 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
10/10/2002US20020147140 Nucleic acids, proteins, and antibodies
10/10/2002US20020147132 Meltrins
10/10/2002US20020146846 Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
10/10/2002US20020146827 Expression vector for use as genetic engineering tool in the amplification of prefeerential products
10/10/2002US20020146824 Novel transcription enhancer element and transcription factor and methods of use thereof
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146794 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
10/10/2002US20020146793 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146786 Bacillus natto culture extract
10/10/2002US20020146779 Methods for production of recombinant polypeptides
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146771 Process for producing erythropoietin containing no animal proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146765 Acetylcholine receptor subunits
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146757 Nucleotide sequences coding polypeptide for use in the treatment of, muscle, blood, nervous system, gastrointestinal and vision defects
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146740 Monitoring ligand binding to membrane proteins; obtain sample containing membrane proteins, incubate with ligands, detect binding of ligands
10/10/2002US20020146732 Method of increasing complementarity in a heteroduplex
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146685 Kit for use in the accurate detection of viral infections
10/10/2002US20020146430 Use of ClyA hemolysin for excretion of proteins
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146397 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002CA2442829A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002CA2442786A1 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002CA2442074A1 Methods of detecting early renal disease in animals
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441382A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 1125